- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00900718
Comparison of Straumann Bone Ceramic and Bio-Oss With Guided Tissue Regeneration for Alveolar Ridge Preservation
Comparison of Straumann Bone Ceramic (SBC) and Bio-Oss in Combination With Guided Tissue Regeneration (GTR) for Volume Preservation of Alveolar Ridge After Tooth Extraction: a Randomised, Single Blind, Controlled Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is prospective, randomized, single-blind, controlled, single center study. The total study duration for each patient should be 12 +/- 1 month.
In total 13 visits per patient are scheduled in this study.
The study devices Straumann Bone Ceramic and Bio-Oss are CE-marked, and approved by the FDA. The products are used within the indication.
One center in the Inited Kingdom will participate.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, WC1X8LD
- Eastman Dental Institute, University College London
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient must have voluntarily signed the informed consent
- Males and females, 18 years to 75 years of age
- Patient needs single tooth extraction in mandibular or maxillary incisor or pre-molar region and would benefit from prosthetic reconstruction with a dental implant
- Patients must be committed to the study and must sign informed consent
- Patient in good general health as documented by self assessment
Exclusion Criteria:
Systemic exclusion criteria
- Patient who has any known diseases (not including controlled diabetes mellitus), infections or recent surgical procedures within 30 days of study initiation
- Female patient who are pregnant or lactating or of child bearing potential not using acceptable methods of birth control (hormonal, barriers or abstinence
- Patient who are on chronic treatment (i.e., two weeks or more) with any medication known to affect oral status (e.g., phenytoin, dihydropyridine calcium antagonists, cyclosporine, and non-steroidal anti-inflammatory drugs) within one month of baseline visit
- Patient who are on concomitant anticoagulant therapy of warfarin (coumadine), clopidogrel, ticlopidine or once daily asprin of more than 81 mg.
- Patient who knowingly has HIV or Hepatitis
- Physical handicaps that would interfere with the ability to perform adequate oral hygiene
- Patient who has undergone administration of any investigational drug within 30 days of study initiation.
- Alcoholism or chronically drug abuse causing systemic compromisation
- Patient who is a heavy smoker (>10/cigarettes per day).
- Patient is suffering from a known psychological disorder
- Patient has limited mental capacity or language skills such that study information cannot be understood, informed consent cannot be obtained, or simple instructions cannot be followed
Local exclusion criteria
- Uncontrolled or untreated periodontal disease
- Bone defects that excludes implant restoration
- Patient who has a full mouth plaque level >30 % at the enrolment visit
- Mucosal diseases such as erosive lichen planus
- History of local radiation therapy
- Presence of oral lesions (such as ulceration, malignancy)
- Severe bruxing or clenching habits
- Persistent intraoral infection
- Patients presenting clinical and radiological signs and symptoms of maxillary sinus disease
- Patient presents an acute endodontic lesion in the test tooth or in the neighbouring areas to the experimental procedure (sites with presence of an asymptomatic chronic lesion are eligible)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Straumann Bone Ceramic
Bone augmentation, after tooth extraction, with Straumann Bone Ceramic (synthetic bone graft material) in combination with resorbable collagen membrane Bio-Gide.
|
Bone augmentation, after tooth extraction, with Straumann Bone Ceramic (synthetic bone graft material) in combination with resorbable collagen membrane Bio-Gide.
Other Names:
|
ACTIVE_COMPARATOR: Bio-Oss
Bone augmentation, after tooth extraction, with Bio-Oss (bovine-derived xenograft)in combination with resorbable collagen membrane Bio-Gide.
|
Bone augmentation, after tooth extraction, with Bio-Oss (bovine-derived xenograft)in combination with resorbable collagen membrane Bio-Gide.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The changes of bone level between baseline and 32 week post-extraction
Time Frame: baseline and 32 week post-extraction
|
baseline and 32 week post-extraction
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
implant success and survival rate
Time Frame: 1 year post implant loading
|
1 year post implant loading
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nikolaos Donos, DDS, MS, PhD, Eastman Dental Institute
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CR 03/05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Loss
-
Alexandria UniversityLehigh UniversityCompletedBone Loss | Horizontal Alveolar Bone Loss | Vertical Alveolar Bone LossEgypt
-
Neva Electromagnetics, LLCMassachusetts General HospitalUnknownBone Loss, Age Related | Age-Related Bone Loss
-
University of Santiago de CompostelaMozo Grau Ticare ImplantsRecruitingPeri-implant Marginal Bone Loss | Peri-implant Bone Level | Transmucosal Abutment Design | Peri-implant Bone LossSpain
-
Faculty of Dental Medicine for GirlsEnrolling by invitationStability, Marginal Bone Loss and Occlusal Load Analysis of PEEK Abutment Supported on Short ImplantMarginal Bone Loss and Loss of Osteointegration of Short ImplantEgypt
-
Dr. Soetomo General HospitalDr. Ramelan Naval Hospital; Airlangga University Hospital; Sidoarjo General Hospital and other collaboratorsRecruiting
-
Mansoura UniversityCompleted
-
University of ValenciaJuan Carlos Bernabeu Mira; Miguel Peñarrocha DiagoCompleted
-
Worcester Polytechnic InstituteNorthwestern UniversityCompleted
-
Mansoura UniversityCompleted
-
Imam Abdulrahman Al Faisal HospitalUnknown
Clinical Trials on Straumann Bone Ceramic
-
Institut Straumann AGCompletedAlveolar Bone Loss | Jaw, Edentulous, PartiallySweden
-
University of OsloTerminatedPeriodontal Diseases | Furcation DefectsNorway
-
University of OsloTerminatedPeriodontal Diseases | Furcation DefectsNorway
-
Miren Vilor FernándezCompleted
-
Institut Straumann AGActive, not recruiting
-
Institut Straumann AGCompletedJaw, Edentulous, PartiallySpain, Germany, United States, Australia, Italy, Sweden, Switzerland
-
Institut Straumann AGCompleted
-
Medical University of GrazRecruitingImmediate Implantation of Two-piece Zirconia Dental ImplantsAustria
-
Shanghai Ninth People's Hospital Affiliated to...National Natural Science Foundation of China; Shanghai Municipal Science and... and other collaboratorsCompletedDental Implants | Sinus Floor Augmentation | Bone RemodelingChina
-
Institut Straumann AGCompletedJaw, Edentulous, PartiallyUnited Kingdom